Rk Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RK PHARMA, and what generic and branded alternatives to RK PHARMA drugs are available?
RK PHARMA has sixteen approved drugs.
There is one tentative approval on RK PHARMA drugs.
Drugs and US Patents for Rk Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rk Pharma | MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 203386-001 | Oct 13, 2017 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Rk Pharma | NADOLOL | nadolol | TABLET;ORAL | 212856-003 | Sep 13, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Rk Pharma | MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 202670-002 | Oct 13, 2017 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Rk Pharma | CUPRIC CHLORIDE | cupric chloride | INJECTABLE;INJECTION | 217626-001 | Apr 30, 2024 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Rk Pharma | DOFETILIDE | dofetilide | CAPSULE;ORAL | 215323-002 | Apr 14, 2022 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Rk Pharma | NADOLOL | nadolol | TABLET;ORAL | 212856-001 | Sep 13, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.